1. Critical Analysis of Drug Product Recalls due to Nitrosamine Impurities;Bharate;J. Med. Chem.,2021
2. Carcinogenic nitrosamines formed by drug- nitrite interactions;Lijinsky;Nature,1972
3. Nitrosamines as environmental carcinogens;Lijinsky;Nature,1970
4. Control of nitrosamine impurities in human drugs: Guidance for industry, U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), 2020, https://www.fda.gov/regulatoryinformation/search-fda-guidance-documents/control-nitrosamineimpurities-human-drugs.
5. NDMA impurity in valsartan and other pharmaceutical products: analytical methods for the determination of N-nitrosamines;Parr;J Pharm Biomed Anal,2019